Quironsalud Madrid
Non-Hodgkin's lymphoma treatment cost in Spain typically starts with a lymphoma blood test ranging from $100 to $300, while primary treatment like chemotherapy runs from $2,500 to $4,500 per cycle. Total expenses depend on the disease stage, specific subtype, and the need for advanced interventions like bone marrow transplantation. Patients often see significant savings compared to the United States. Top medical hubs include Barcelona, Madrid, and Pamplona.
Typical Non-Hodgkin's Lymphoma Treatment Costs in Spain
Bookimed Expert Insight: Patients seeking the highest clinical standards should prioritize JCI-accredited centers like Clinica Universidad de Navarra. For complex pediatric cases, SJD Barcelona Children’s Hospital is a top-3 European oncology leader. Individuals interested in cutting-edge research may find value at Quironsalud Madrid, which offers clinical trials. Families often choose Centro Médico Teknon for its high-profile reputation and specialist expertise in adult oncohematology.
HM Hospitales — to grupa 7 wiodących hiszpańskich klinik zlokalizowanych w Madrycie (Hiszpania).
Specjalizacja — onkologia dorosłych i dzieci, neurologia, neurochirurgia, kardiologia i ortopedia.
W 2018 roku 5 spośród 7 szpitali znalazło się w TOP najlepszych prywatnych klinik w Hiszpanii według Organizacji Monitorowania Reputacji Medycznej MERCO.
Corocznie chirurdzy HM wykonują ponad 26 000 operacji, a leczenie raka przechodzi tutaj około 2 500 pacjentów.
Specjalistka w zakresie przeszczepiania szpiku kostnego – dr Rives Sola koncentruje się na hematologii dziecięcej w szpitalu dziecięcym SJD Barcelona Children’s Hospital.
Dr Graupera kieruje Oddziałem Hematologii i Onkologii w Szpitalu Sant Joan De Déu – jednej z najlepszych placówek dziecięcych w Europie. Jego badania naukowe koncentrują się na metodach leczenia nowotworów u dzieci.
Ponad 1100 wykonanych zabiegów onkologicznych – dr Cobo Valien specjalizuje się w leczeniu chłoniaków w Centro Médico Teknon.
Profesor Bosch jest światowej sławy liderem w dziedzinie przewlekłej białaczki limfocytowej (PBL) oraz schorzeń limfoproliferacyjnych, wprowadzającym pionierskie metody leczenia i technologie.
Spain hosts globally recognized oncology centers like Quironsalud Madrid and Centro Medico Teknon. These facilities provide advanced care for Non-Hodgkin’s lymphoma through JCI-accredited programs. They offer specialized hematology units, academic CAR T-cell therapy, and complex bone marrow transplants for adult and pediatric cases.
Bookimed Expert Insight: Patient volume is a primary indicator of quality in Spain. Quironsalud Madrid and Clinica Universidad de Navarra serve 140,000 to 450,000 patients annually. High-volume centers often offer broader access to clinical trials for refractory lymphoma. This volume allows surgeons like Dr. Francesc Bosch to manage 80+ active research studies simultaneously.
Patient Consensus: Patients emphasize finding a hospital with a dedicated hematology team rather than general oncology. They note that getting a second opinion on pathology is vital for confirming specific lymphoma subtypes.
Spain features top onco-hematologists specialized in Non-Hodgkin lymphoma at JCI-accredited centers like Centro Médico Teknon and Quironsalud Madrid. Specialists such as Prof. Dr. Francesc Bosch and Dr. Francesc Cobo Valien provide advanced immunotherapy and bone marrow transplant protocols within academic research environments.
Bookimed Expert Insight: Our data shows that top Spanish centers like Quironsalud Madrid and HM Madrid serve up to 400,000 patients annually. For lymphoma, this high volume is critical because centers that perform more bone marrow transplants often report better outcomes. Some facilities even offer free treatment to international patients who qualify for their active phase 1 to 3 oncology clinical trials.
Patient Consensus: Patients emphasize finding a hospital with a dedicated hematopathology team, as getting the exact lymphoma subtype correct is essential for choosing the right treatment. They also note that major university hospitals prioritize multidisciplinary tumor boards where several specialists review each complex case together.
Spain provides advanced CAR T-cell therapy for relapsed or refractory Non-Hodgkin lymphoma through a network of accredited centers. Treatment includes commercial therapies like Yescarta and Kymriah. Specialized hospitals in Barcelona and Madrid also manufacture academic CAR-T protocols for complex or treatment-resistant cases.
Bookimed Expert Insight: Spain’s unique hospital exemption model allows institutions to create in-house CAR-T protocols. This helps patients who have already failed standard commercial CAR-T treatments. Hospitals like Quironsalud Madrid and Clinica Universidad de Navarra maintain high quality standards with JCI and Newsweek recognition. While 83 clinics are available in Spain, choosing a hub with a high volume of clinical trials like Quironsalud Madrid can provide access to emerging therapies not found in standard packages.
Patient Consensus: Patients emphasize that speed is vital because the disease progresses quickly. They note that getting a second opinion at a major tertiary center helps speed up the referral process.
Spain personalizes lymphoma treatment through genomic profiling by utilizing advanced genetic mapping to identify distinct molecular subtypes and predict drug resistance. Clinics use custom Next-Generation Sequencing panels to sequence tumor DNA. This precision approach helps select targeted immunotherapies and optimize chemotherapy intensity for non-Hodgkin's lymphoma.
Bookimed Expert Insight: Spanish centers like Clinica Universidad de Navarra and Teknon prioritize high-volume diagnostic throughput to refine precision protocols. Navarra has treated over 700,000 international patients and was the first in Spain to receive JCI accreditation. This massive data pool allows surgeons to identify rare genetic variations that smaller clinics might miss. When choosing a facility, look for those with integrated molecular laboratories, like SJD Barcelona, which processes 450,000 patients annually to ensure genomic accuracy.
Patient Consensus: Patients note it is important to have a specialized hematologist who explains how genetic markers affect the treatment plan. They often feel more confident when clinics provide real-time monitoring through blood tests rather than repeated invasive biopsies.
Health insurance rarely covers pre-existing lymphoma for foreign travelers in Spain. Coverage depends on nationality and specific policy riders. EU citizens with an EHIC card can access public oncology services. Non-EU travelers usually pay out-of-pocket unless they hold specialized medical insurance for chronic conditions.
Bookimed Expert Insight: Spain’s specialized oncology centers like Clinica Universidad de Navarra or Centro Médico Teknon often manage high-complexity cases. While coverage is rare for tourists, these centers maintain specific protocols for international billing. Private oncology consultations with specialists like Dr. Francesc Bosch may require direct payment. Always secure a written cost estimate or insurer guarantee before beginning diagnostic workups in Barcelona or Madrid.
Patient Consensus: Patients note a sharp distinction between emergency stabilization and ongoing oncology care. Many warn that insurers frequently deny claims for scans or blood tests if they relate to a known lymphoma diagnosis.
Spanish hospitals provide specialized international patient departments for foreign arrivals. These dedicated units coordinate medical visa assistance, multilingual interpretation, and fast-track scheduling in under 72 hours. Administrative services include direct insurance billing management and remote telemedicine to review diagnostics prior to departure.
Bookimed Expert Insight: Spanish centers like Clinica Universidad de Navarra and Quironsalud Madrid demonstrate extreme patient volumes, serving up to 700,000 international visitors annually. Data shows that large networks like HM Hospitales revolutionize care by offering 24/7 coordination across seven specialized facilities. This high-volume infrastructure allows them to maintain specific pediatric and adult oncology departments that smaller regional clinics typically lack.
Patient Consensus: Patients note that private hospitals offer a much more organized experience than public systems, particularly for fast second opinions. They recommend arriving with all pathology reports and scans already translated to speed up the treatment planning process.
Lymphoma patients in Spain must prioritize UV protection and infection control. Chemotherapy often increases skin photosensitivity. High-UV exposure and crowded tourist hubs pose specific risks. Patients should avoid peak sun hours. Wearing high-filtration masks in dense transit areas like the Madrid Metro is essential.
Bookimed Expert Insight: While Spain ranks 6th globally for medical tourism, patients often overlook the sheer scale of the top facilities. Large centers like Quironsalud Madrid or HM Madrid serve millions of outpatients annually. High patient volumes mean hospitals are highly efficient but public transport to them is often crowded. Patients should plan private transfers for appointments rather than relying on the Metro to minimize exposure to seasonal respiratory viruses during treatment.
Patient Consensus: Patients emphasize staying away from areas with visible mold or ongoing construction to avoid fungal spores. They suggest prioritizing high hand hygiene standards in busy Mediterranean tourist spots and sticking to freshly cooked, hot meals to prevent gastrointestinal issues.